Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Allergy & Immunology
Dermatomyositis
Questions discussed in this category
Should IVIg dosing in patients with autoimmune disease (i.e., dermatomyositis) who become pregnant continue to be based on actual weight at the time of each infusion, or should it be limited to pre-pregnancy weight?
2 Answers available
Would you avoid combining JAK inhibitors with IVIG given the risk of thromboembolism?
4 Answers available
21674
16802
Papers discussed in this category
N Engl J Med, 2022 Oct 06
Trial of Intravenous Immune Globulin in Dermatomyositis.
Medicine, 2021 Jan 08
Prospective, double-blind, randomized, placebo-controlled phase III study evaluating efficacy and safety of octagam 10% in patients with dermatomyositis ("ProDERM Study").
Curr Rheumatol Rep, 2023 Aug
Intravenous Immunoglobulin in Idiopathic Inflammatory Myopathies: a Practical Guide for Clinical Use.
NeoReviews, 2021 Jan
Update on the Use of Intravenous Immunoglobulin in Pregnancy.
Journal of clinical pharmacology, 2023 Jun
Physiologic Changes During Pregnancy and Impact on Small-Molecule Drugs, Biologic (Monoclonal Antibody) Disposition, and Response.
Related Topics in Allergy & Immunology
Breast Cancer
Hematologic Malignancies
Radiation Oncology
Pediatric Hematology/Oncology
Medical Oncology
Bone Marrow Transplant
Biologic Therapy/Immunobiology
Internal Medicine
Rheumatology
ALL